BillionToOne launched its expanded Unity Fetal Risk Screen on August 17, 2026. The 130-gene panel is the largest non-invasive prenatal testing (NIPT) option for single-gene recessive conditions currently on the market.
Management expects the expansion to appeal to the 50% of healthcare providers who prefer comprehensive screening. This strategy aims to broaden the company's addressable market and strengthen its leadership in the prenatal sector.
The company previously disclosed the launch timeline during its second-quarter earnings report on August 5, 2026.